Movement Disorder Virtual University WE MOVE
Research News
E-MOVE - Research News Service Subscribe to E-MOVE

Search Research News
Any Words All Words Exact Phrase

E-MOVE Archives 2001

ID date title
291 1/1/2001 BOTOX Receives FDA Approval for Cervical Dystonia
292 1/8/2001 Prevalence of Dystonia in Europe
293 1/9/2001 PD Mortality With and Without Selegiline
294 1/11/2001 HD: Inactivation of Huntingtin; Carbamazepine for Precipitate Micturition
295 1/17/2001 CBD, Aphasia and Dementia; New Model for Tauopathies
296 2/2/2001 DRD Diagnosis: Genetic Analysis, Imaging Case Reports
297 2/9/2001 HD Fetal Transplants Display Appropriate Morphology and Lack of Pathology
298 2/13/2001 Comparison of Newer PD Drugs
299 2/19/2001 Rasagiline as Levodopa Adjunct in Fluctuating PD
300 2/20/2001 Overdiagnosis of Essential Tremor
301 3/1/2001 MSA: Sleep Disturbance and Treatment; Possible Role for Adrenergic Receptor
302 3/2/2001 PD: D1 Receptor Agonist Treatment; Value of Challenge Tests in Diagnosis
303 3/8/2001 Pallidotomy: Neuropsychological Outcomes, Targeting
304 3/21/2001 Announcement: Documentary on Xenotransplantation
305 3/22/2001 Tics and TS: Epidemiology, QOL
306 3/23/2001 Baclofen and BTX-A for Tics/TS
307 3/23/2001 Announcement: Clinical Trials Database
308 3/28/2001 Announcement: Updated Spasticity Teaching Slides Available for Download
309 3/29/2001 HD: Proposed Mechanism of Action of Mutant Huntingtin
310 4/3/2001 CP: Physiotherapy, Electrical Stimulation
311 4/6/2001 The Rett Syndrome Protein Acts in Post-Mitotic Neurons
312 4/7/2001 Announcement: New Movement Disorder Pages on the WE MOVE Web Site
313 4/12/2001 Dysport Potency is Increased by Dilution and Albumin Supplementation
314 4/16/2001 Ten-Year Pallidotomy Follow-Up
315 4/25/2001 Ataxia: CoQ10 Deficiency, Friedreich's Mouse Model
316 4/30/2001 Announcement: AAN Reports Coming Soon
317 5/6/2001 RLS: Severity Rating Tool, Autosomal Dominant Inheritance
318 5/8/2001 RLS Self-Administered Diagnosistic Questionnaire (AAN 2001)
319 5/8/2001 Tetrabenazine for Huntington's Disease (AAN 2001)
320 5/8/2001 ITB: Use in Ambulatory Patients; Combination With Morphine (AAN 2001)
321 5/9/2001 Ropinirole for Tourette Syndrome (AAN 2001)
322 5/14/2001 Costs and Reimbursement of PD (AAN 2001)
323 5/14/2001 Functional Improvement From BTX-A in Post-Stroke Spasticity (AAN 2001)
324 5/15/2001 Non-Motor Fluctuations in PD (AAN 2001)
325 5/16/2001 Dopamine Agonists for RLS (AAN 2001)
326 5/18/2001 Treatment for Dementia in PD (AAN 2001)
327 5/18/2001 Experimental Surgical Treatments for PD (AAN 2001)
328 5/19/2001 HD: Amantadine for Chorea, Reversal of Pathology in Mice, No Effect from Creatine (AAN 2001)
329 5/22/2001 DBS Surgery Complications; Subthalamotomy (AAN 2001)
330 5/22/2001 DBS Targeting (AAN 2001)
331 5/23/2001 Prevalence and Treatment of Excess Daytime Sleepiness in PD (AAN 2001)
332 5/23/2001 Dystonia: Rating Scale, Cannabinoid Stimulation (AAN 2001)
333 5/25/2001 Announcement: ET Teaching Slides, AAN 2001 Reports on the WE MOVE Web Site
334 6/8/2001 Evidence-Based Medicine in Botulinum Toxin Treatment (Journal Contents)
335 6/11/2001 Chronic Levodopa Is Not Toxic and May Promote Recovery of Dopaminergic Neurons
336 6/16/2001 Mutant Huntingtin Impairs the Proteasome
337 6/20/2001 Announcement: Parkinson's Fast-Track Grants Available
338 6/22/2001 BTX-A for Pain in CD (WCN 2001)
339 6/22/2001 Alternative Levodopa Administration Strategies (WCN 2001)
340 6/25/2001 New Locus for Early-Onset PD (WCN 2001)
341 6/26/2001 Announcement: PD Meeting Helsinki
342 6/27/2001 Anti-Gluten Antibodies Are Common in Sporadic Ataxia (WCN 2001)
343 6/28/2001 BTX-B for Spasticity (WCN 2001)
344 6/29/2001 One Hundred Cases of Wilson Disease (WCN 2001)
345 7/3/2001 Treatment of Rare Movement Disorders (WCN 2001)
346 7/3/2001 Permanganate-Induced Parkinsonism; Spinal Cord Pathology in PSP (WCN 2001)
347 7/3/2001 Focal Dystonia Genetics (WCN 2001)
348 7/4/2001 BTX Dosing (WCN 2001)
349 7/4/2001 Gabapentin for Spasticity, RLS (WCN 2001)
350 7/9/2001 Risk From Diathermy with DBS Electrodes
351 7/9/2001 CP Treatments: Hyperbaric Oxygen, ITB, Orthoses
352 7/16/2001 Announcement: New CD Information on the WE MOVE Web Site
353 7/16/2001 Reminder: Fast Track PD Grant Deadline is July 19th
355 7/23/2001 Proteasomal Impairment in PD
354 7/23/2001 Announcement: World Congress of Disabilities Meeting
356 7/27/2001 Gene for Chorea-Acanthocytosis Found
357 7/27/2001 Surgery for Dystonia
359 7/28/2001 Dyskinesias Correlate with Decreased Mental Health and Increase Health Costs (PD Congress 2001)
358 7/28/2001 High-Dose Pergolide Can Substitute for Levodopa (PD Congress 2001)
360 7/30/2001 Parkin: Localization, Pathologic Basis of Mutation (PD Congress 2001)
362 7/30/2001 Neurotransmitter Abnormalities in ET Brain, SSRI Treatment in Model of PD (PD Congress 2001)
361 7/30/2001 Genotypic Basis of Tolcapone Sensitivity (PD Congress 2001)
363 8/3/2001 Ultrasound Abnormalities in the Substantia Nigra (PD Congress 2001)
365 8/3/2001 Levodopa Pharmacokinetics (PD Congress 2001)
364 8/3/2001 Sublingual Atropine for Sialorrhea (PD Congress 2001)
366 8/3/2001 No Acceleration of Dyskinesias After Ropinirole Monotherapy (PD Congress 2001)
368 8/4/2001 Depression in PD: Prevalence and Correlates (PD Congress 2001)
370 8/4/2001 Rasagiline for Early PD (PD Congress 2001)
367 8/4/2001 Mixed Results from Rotigotine Patch (PD Congress 2001)
369 8/4/2001 Depression in PD: Treatment (PD Congress 2001)
371 8/6/2001 MSA Diagnosis, Lamotrigine Trial (PD Congress 2001)
372 8/6/2001 High-Dose Ropinirole (PD Congress 2001)
374 8/7/2001 Cabergoline Tolerability in Elderly Patients (PD Congress 2001)
376 8/7/2001 Thalamotomy vs. Thalamic Stimulation for Tremor (PD Congress 2001)
378 8/7/2001 Gene Microarrays Track Neurodegeneration, Protection (PD Congress 2001)
373 8/7/2001 Experimental Surgeries (PD Congress 2001)
375 8/7/2001 PD Genetics: Cuban Kindred Without Known Mutations; Haploinsufficiency of Parkin (PD Congress 2001)
377 8/7/2001 Sexual Function, Caregiver Stress in PD (PD Congress 2001)
379 8/8/2001 Sleep Disorders and Sleep Attacks (PD Congress 2001)
381 8/14/2001 Announcement: PD Congress Reports Archived On WE MOVE Site
380 8/14/2001 Announcement: New Sydenham's Chorea Page on the WE MOVE site
382 8/27/2001 Parkin Substrates Include a Novel Alpha-Synuclein and a Plasma Membrane Receptor
384 8/29/2001 Long-Term Follow-up of Tardive Dyskinesia
383 8/29/2001 Treatment of Rare Movement Disorders
385 8/30/2001 Hallervorden-Spatz Gene Defect, New Basal Ganglia Disease Both Implicate Iron
386 9/13/2001 Announcement: Research Grants for Cell Line Development
387 9/14/2001 Post-Stroke Spasticity Treatment
388 10/2/2001 Announcement: RLS Teaching Slide Set Available
389 10/3/2001 PSP Diagnosis and Treatment
391 10/4/2001 Treatment of Essential Tremor
390 10/4/2001 Tau in PSP and CBD
392 10/5/2001 Dyskinesias in PD: Frequency and Mechanism
393 10/5/2001 Alpha-synuclein Aggregates Damage Vesicles
394 10/12/2001 Microinjections to Human STN Support Basal Ganglia Model
395 10/15/2001 Vitamin B6 for Tardive Dyskinesia
396 10/18/2001 Huntington's Disease Treatments
397 10/20/2001 Hallervorden-Spatz Syndrome (Journal Contents)
398 10/24/2001 Announcement: New HD, HSP Pages on the WE MOVE Site
399 10/24/2001 Dystonia Treatments: DBS, Morphine
400 10/25/2001 Announcement: Meeting Report Follow-up: Published Manuscripts
402 12/19/2001 Triplet Repeat Diseases Special Issue (Journal Contents)
403 12/19/2001 A Message from WE MOVE
404 12/20/2001 Whole-Genome Screen for PD Implicates Tau

 
All contents copyright © WE MOVE 2010. This page last modified 3/5/2008.